TG and breast cancer: An increased prevalence of melanoma, colon cancer, breast cancer, and hematological malignancies in patients suffering from GD or HT has been identified, but the overall risk for breast, colon, kidney, and uterine cancer was lower in patients with anti-TPO and anti-Tg antibodies than without (133).